Myomar Molecular Inc.
Myomar Molecular is a health diagnostics company developing the first, non-invasive molecular detection device and multiplex test for muscle loss. Over 80 percent of hospitalizations related to injury among seniors are due to falls; current muscle-monitoring methods are ineffective in accurately detecting muscle loss, are invasive, or costly. Myomar’s technology predicts fall risk and facilitates better-informed care decisions among the world’s ageing population.